ROY A WHITFIELD Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROY A WHITFIELD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROY A WHITFIELD. ROY A WHITFIELD is Director in INCYTE CORP ($INCY) and Director in NEKTAR THERAPEUTICS ($NKTR) and Director in ILLUMINA INC ($ILMN).
Latest Insider Trading Transactions of ROY A WHITFIELD
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ILMN, INCY, NKTR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Gift | G | 0.00 | 51,500 | 0 | 51,500 | 0 to 51.5 K |
| Jan 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Gift | G | 0.00 | 51,500 | 0 | 185,850 | 237.4 K to 185.9 K (-21.70 %) |
| Sep 24 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 18.91 | 18,200 | 344,162 | 18,200 | |
| Sep 24 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 9,100 | 0 | 237,350 | 228.3 K to 237.4 K (+3.99 %) |
| Sep 08 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 9.24 | 30,000 | 277,200 | 0 | |
| Sep 08 2020 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 9.24 | 30,000 | 277,200 | 228,250 | 198.3 K to 228.3 K (+15.13 %) |
| Dec 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 9.24 | 10,000 | 92,400 | 30,000 | |
| Dec 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 9.24 | 10,000 | 92,400 | 198,250 | 188.3 K to 198.3 K (+5.31 %) |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 6,500 | 0 | 188,250 | 181.8 K to 188.3 K (+3.58 %) |
| Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 60.91 | 9,500 | 578,645 | 9,500 | |
| Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 4,750 | 0 | 181,750 | 177 K to 181.8 K (+2.68 %) |
| Jun 07 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | P | 59.80 | 1,400 | 83,720 | 177,000 | 175.6 K to 177 K (+0.80 %) |
| Jun 07 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | P | 59.07 | 2,000 | 118,140 | 175,600 | 173.6 K to 175.6 K (+1.15 %) |
| Jun 07 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | P | 55.22 | 1,600 | 88,352 | 173,600 | 172 K to 173.6 K (+0.93 %) |
| Apr 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 14.26 | 30,000 | 427,800 | 0 | |
| Apr 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 14.26 | 30,000 | 427,800 | 172,000 | 142 K to 172 K (+21.13 %) |
| Sep 21 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 21.75 | 22,500 | 489,375 | 22,500 | |
| Sep 21 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 9,000 | 0 | 142,000 | 133 K to 142 K (+6.77 %) |
| Aug 14 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | P | 17.95 | 35,000 | 628,250 | 133,000 | 98 K to 133 K (+35.71 %) |
| Mar 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 8.37 | 14,000 | 117,180 | 0 | |
| Mar 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 8.37 | 14,000 | 117,180 | 98,000 | 84 K to 98 K (+16.67 %) |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 5.14 | 30,000 | 154,200 | 0 | |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 8.37 | 1,000 | 8,370 | 14,000 | |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 5.15 | 15,000 | 77,250 | 0 | |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 5.14 | 30,000 | 154,200 | 84,000 | 54 K to 84 K (+55.56 %) |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 8.37 | 1,000 | 8,370 | 54,000 | 53 K to 54 K (+1.89 %) |
| Sep 27 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 5.15 | 15,000 | 77,250 | 53,000 | 38 K to 53 K (+39.47 %) |
| Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 19.15 | 20,000 | 383,000 | 20,000 | |
| Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Grant | A | 0.00 | 8,000 | 0 | 38,000 | 30 K to 38 K (+26.67 %) |
| Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 0.00 | 15,000 | 0 | 30,000 | 15 K to 30 K (+100.00 %) |
| Aug 15 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 42.82 | 4,000 | 171,280 | 3,500 | |
| Aug 15 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 167.22 | 4,000 | 668,880 | 2,853 | 6.9 K to 2.9 K (-58.37 %) |
| Aug 15 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 42.82 | 4,000 | 171,280 | 6,853 | 2.9 K to 6.9 K (+140.20 %) |
| Jun 15 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 42.82 | 2,000 | 85,640 | 7,500 | |
| Jun 15 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 140.44 | 3,800 | 533,672 | 2,853 | 6.7 K to 2.9 K (-57.12 %) |
| Jun 15 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 42.82 | 2,000 | 85,640 | 6,653 | 4.7 K to 6.7 K (+42.98 %) |
| May 19 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Grant | A | 0.00 | 2,853 | 0 | 4,653 | 1.8 K to 4.7 K (+158.50 %) |
| Feb 16 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 36.29 | 3,750 | 136,088 | 0 | |
| Feb 16 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 140.30 | 3,750 | 526,125 | 1,800 | 5.6 K to 1.8 K (-67.57 %) |
| Feb 16 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 36.29 | 3,750 | 136,088 | 5,550 | 1.8 K to 5.6 K (+208.33 %) |
| Apr 14 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 42.82 | 4,000 | 171,280 | 9,500 | |
| Apr 14 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 170.00 | 4,000 | 680,000 | 1,800 | 5.8 K to 1.8 K (-68.97 %) |
| Apr 14 2016 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 42.82 | 4,000 | 171,280 | 5,800 | 1.8 K to 5.8 K (+222.22 %) |
| Dec 15 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 36.29 | 3,750 | 136,088 | 3,750 | |
| Dec 15 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 175.07 | 3,750 | 656,513 | 13,648 | 17.4 K to 13.6 K (-21.55 %) |
| Dec 15 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 36.29 | 3,750 | 136,088 | 17,398 | 13.6 K to 17.4 K (+27.48 %) |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Sep 15 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | M | 8.81 | 15,000 | 132,150 | 0 | |
| Sep 15 2015 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Buy | M | 8.81 | 15,000 | 132,150 | 15,000 | 0 to 15 K |
| Sep 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 36.29 | 4,500 | 163,305 | 7,500 | |
| Sep 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 36.29 | 3,000 | 108,870 | 12,000 | |
| Sep 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 39.14 | 1,500 | 58,710 | 0 | |
| Sep 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 192.63 | 4,500 | 866,835 | 13,648 | 18.1 K to 13.6 K (-24.80 %) |
| Sep 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 36.29 | 4,500 | 163,305 | 18,148 | 13.6 K to 18.1 K (+32.97 %) |
| Sep 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 215.22 | 4,500 | 968,490 | 13,648 | 18.1 K to 13.6 K (-24.80 %) |
| Sep 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 36.29 | 3,000 | 108,870 | 18,148 | 15.1 K to 18.1 K (+19.80 %) |
| Sep 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 39.14 | 1,500 | 58,710 | 15,148 | 13.6 K to 15.1 K (+10.99 %) |
| Jul 07 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 39.14 | 4,500 | 176,130 | 1,500 | |
| Jul 07 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 218.70 | 500 | 109,350 | 13,648 | 14.1 K to 13.6 K (-3.53 %) |
| Jul 07 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 218.26 | 1,300 | 283,738 | 14,148 | 15.4 K to 14.1 K (-8.42 %) |
| Jul 07 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 218.00 | 1,200 | 261,600 | 15,448 | 16.6 K to 15.4 K (-7.21 %) |
| Jul 07 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 217.86 | 1,500 | 326,790 | 16,648 | 18.1 K to 16.6 K (-8.27 %) |
| Jul 07 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 39.14 | 4,500 | 176,130 | 18,148 | 13.6 K to 18.1 K (+32.97 %) |
| Jun 08 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 39.14 | 4,500 | 176,130 | 6,000 | |
| Jun 08 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 207.49 | 4,500 | 933,705 | 13,648 | 18.1 K to 13.6 K (-24.80 %) |
| Jun 08 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 39.14 | 4,500 | 176,130 | 18,148 | 13.6 K to 18.1 K (+32.97 %) |
| May 28 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Grant | A | 0.00 | 1,910 | 0 | 13,648 | 11.7 K to 13.6 K (+16.27 %) |
| May 07 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 39.14 | 4,500 | 176,130 | 10,500 | |
| May 07 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 188.42 | 4,500 | 847,890 | 11,738 | 16.2 K to 11.7 K (-27.71 %) |
| May 07 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 39.14 | 4,500 | 176,130 | 16,238 | 11.7 K to 16.2 K (+38.34 %) |
| Apr 08 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 19.61 | 4,600 | 90,206 | 0 | |
| Apr 08 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 181.32 | 4,600 | 834,072 | 11,738 | 16.3 K to 11.7 K (-28.16 %) |
| Apr 08 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 19.61 | 4,600 | 90,206 | 16,338 | 11.7 K to 16.3 K (+39.19 %) |
| Mar 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Option Exercise | M | 19.61 | 4,600 | 90,206 | 4,600 | |
| Mar 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 195.31 | 1,537 | 300,192 | 11,738 | 13.3 K to 11.7 K (-11.58 %) |
| Mar 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 194.77 | 2,463 | 479,706 | 13,275 | 15.7 K to 13.3 K (-15.65 %) |
| Mar 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 193.13 | 400 | 77,250 | 15,738 | 16.1 K to 15.7 K (-2.48 %) |
| Mar 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Sell | S | 191.80 | 200 | 38,360 | 16,138 | 16.3 K to 16.1 K (-1.22 %) |
| Mar 09 2015 | ILMN | ILLUMINA INC | WHITFIELD ROY A | Director | Buy | M | 19.61 | 4,600 | 90,206 | 16,338 | 11.7 K to 16.3 K (+39.19 %) |
| Mar 11 2005 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Option Exercise | M | 0.00 | 50,000 | 0 | 0 | |
| Mar 11 2005 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Payment of Exercise | F | 7.24 | 18,737 | 135,656 | 983,389 | 1 M to 983.4 K (-1.87 %) |
| Mar 11 2005 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Buy | M | 0.00 | 50,000 | 0 | 1,002,126 | 952.1 K to 1 M (+5.25 %) |
| May 27 2004 | INCY | INCYTE CORP | WHITFIELD ROY A | Director | Option Exercise | A | 7.02 | 10,000 | 70,200 | 10,000 |
Page: 1